0001562180-21-003139.txt : 20210504 0001562180-21-003139.hdr.sgml : 20210504 20210504163421 ACCESSION NUMBER: 0001562180-21-003139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210430 FILED AS OF DATE: 20210504 DATE AS OF CHANGE: 20210504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Donovan Joanne M. CENTRAL INDEX KEY: 0001644087 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 21889082 MAIL ADDRESS: STREET 1: C/O CATABASIS PHARMACEUTICALS, INC. STREET 2: ONE KENDALL SQ. BLDG. 1400E SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O ORBIMED ADVISORS LLC STREET 2: 601 LEXINGTON AVE, 54TH FLR. CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-739-6451 MAIL ADDRESS: STREET 1: C/O ORBIMED ADVISORS LLC STREET 2: 601 LEXINGTON AVE, 54TH FLR. CITY: NEW YORK STATE: NY ZIP: 10022 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-04-30 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001644087 Donovan Joanne M. C/O EDGEWISE THERAPEUTICS, INC. 3145 COLORADO AVE BOULDER CO 80303 false true false false CMO Stock Option (Right to Buy) 28.64 2021-04-30 4 A false 160000.00 0.00 A 2031-04-30 Common Stock 13964.00 160000.00 D 1/4th of the shares subject to the option will become vested and exercisable on April 26, 2022 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date. John R. Moore Attorney-in-Fact for Donovan Joanne M. 2021-05-04